U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 208447
Company: GLAXOSMITHKLINE
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ZEJULA NIRAPARIB TOSYLATE EQ 100MG BASE CAPSULE;ORAL Discontinued None Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/27/2017 ORIG-1 Approval Type 1 - New Molecular Entity PRIORITY; Orphan Label (PDF)
Letter (PDF)
Review
httpS://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208447Orig1s000Ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208447_zejula_toc.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/26/2023 SUPPL-27 Efficacy-Labeling Change With Clinical Data Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208447s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208447Orig1s027ltr.pdf
09/14/2022 SUPPL-26 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208447s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/208447Orig1s026ltr.pdf
12/08/2022 SUPPL-25 Efficacy-Labeling Change With Clinical Data Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208447s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/208447Orig1s025ltr.pdf
07/27/2021 SUPPL-24 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s022s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208447Orig1s022,s024ltr.pdf
07/27/2021 SUPPL-22 Labeling-Container/Carton Labels Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s022s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208447Orig1s022,s024ltr.pdf
03/03/2021 SUPPL-20 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s019s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208447Orig1s019, s020ltr.pdf
03/03/2021 SUPPL-19 Labeling-Package Insert, Labeling-Container/Carton Labels Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s019s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208447Orig1s019, s020ltr.pdf
05/29/2020 SUPPL-18 Labeling-Container/Carton Labels Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208447Orig1s018ltr.pdf
04/29/2020 SUPPL-17 Efficacy-New Indication Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208447s015s017lbledt.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208447Orig1s015, s017ltr.pdf
04/29/2020 SUPPL-15 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208447s015s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208447Orig1s015, s017ltr.pdf
10/23/2019 SUPPL-14 Efficacy-New Indication Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208447s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208447Orig1s014ltr.pdf
02/26/2020 SUPPL-12 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208447s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208447Orig1s012ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
04/26/2023 SUPPL-27 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208447s027lbl.pdf
12/08/2022 SUPPL-25 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208447s025lbl.pdf
09/14/2022 SUPPL-26 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208447s026lbl.pdf
07/27/2021 SUPPL-24 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s022s024lbl.pdf
07/27/2021 SUPPL-22 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s022s024lbl.pdf
03/03/2021 SUPPL-20 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s019s020lbl.pdf
03/03/2021 SUPPL-19 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s019s020lbl.pdf
03/03/2021 SUPPL-19 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208447s019s020lbl.pdf
04/29/2020 SUPPL-17 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208447s015s017lbledt.pdf
04/29/2020 SUPPL-15 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208447s015s017lbl.pdf
02/26/2020 SUPPL-12 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208447s012lbl.pdf
10/23/2019 SUPPL-14 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208447s014lbl.pdf
03/27/2017 ORIG-1 Approval Label (PDF) httpS://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf
Back to Top